Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve thiol-related catalyst poisoning and high-cost precious metals in thioester synthesis. This nickel-catalyzed method uses arylsulfonyl chloride as sulfur source, offering high yields (50-74%) and broad functional group tolerance for reliable API manufacturing.
Solve supply chain risks in indolo[2,1a]isoquinoline production with CO substitute technology. 92% yield, 24h reaction, and broad functional group tolerance for API manufacturing.
Discover high-yield, functional group-tolerant 3-alkynyl indole synthesis via palladium-catalyzed tandem reaction. Solve supply chain risks for pharma intermediates with scalable production.
Solve high palladium costs & low yields in sartanbiphenyl synthesis. Our nickel-catalyzed method achieves >85% yield, 98% purity, and clean manufacturing. Scale to 100MT/yr.
Discover a one-step, high-yield synthesis of quinoline-4(1H)-one using cheap reagents. Eliminate supply chain risks and reduce production costs for your API development.
Discover how metal-free heating-promoted synthesis of 5-trifluoromethyl-1,2,4-triazole reduces catalyst costs and supply chain risks for pharmaceutical intermediates. Scale-ready solution for R&D and production teams.
Solve sesamin precursor synthesis challenges with this rare earth metal method. 60-90% yield, air-stable operation, and reduced supply chain risks for pharma R&D and production.
New synthesis method for pseudouridine intermediate reduces costs by 30% with 82% yield. Simplified process eliminates expensive reagents and complex quenching steps for stable supply chain.
Solve supply chain risks with a 4-step, 26.9% yield synthesis for pyridine-8-carboxylic acid (CAS 1314378-07-8). Our CDMO expertise ensures industrial scalability and high purity.
Avoid hazardous reagents and -78°C conditions with this scalable 2,8-dioxaspiro[4.5]decan-1-one synthesis. 92% yield, 84% purity. Reduce supply chain risks.
Discover a cost-effective, scalable method for indole/benzoxazine synthesis with high functional group tolerance. Reduce R&D costs and supply chain risks with this palladium-catalyzed carbonylation process.
Solve arylstannane synthesis challenges with 95% yields, no metal catalysts, and room-temperature processing. Reduce costs and supply chain risks for pharmaceutical intermediates.
Solve supply chain risks with this metal-free, high-yield synthesis. NINGBO INNO PHARMCHEM scales 3-hydroxymethyl-4-phenyl-3,4-dihydroquinolinone for pharma R&D and production.
Discover high-yield renieramycins intermediate synthesis with 89% yield, L-tyrosine-based cost reduction, and industrial scalability for pharmaceutical R&D and procurement teams.
Eliminate heavy metal residues and high costs in 3-hydroxy-2-indolone production with this novel metal-free synthesis method. Scale up efficiently with our CDMO expertise.
Discover a scalable, high-yield synthesis of E-type benzofulvene derivatives with excellent stereoselectivity. Reduce R&D costs and ensure supply chain stability for your API production.
Solve supply chain risks with novel Pd-catalyzed cascade synthesis of polycyclic 3,4-dihydro-2(1H)-quinolinone. High yield, broad functional group tolerance, and scalable production for pharma intermediates.
Eliminate metal catalysts and high-pressure hydrogenation risks in PF-06651600 synthesis. Our scalable, high-yield route ensures 99% purity and supply chain stability for alopecia areata treatments.
Solve supply chain risks with this novel 5-trifluoromethyl imidazole synthesis. 99%+ purity, scalable to 100MT/yr, and 95%+ yield. Contact for custom synthesis.
Solve supply chain risks with 82% yield, room-temperature operation, and simplified purification for thiochromanone derivatives. Contact us for scalable production.